2015
DOI: 10.1080/08927022.2015.1044451
|View full text |Cite
|
Sign up to set email alerts
|

Predicting substrate selectivity between UGT1A9 and UGT1A10 using molecular modelling and molecular dynamics approach

Abstract: Uridine 5 0 -diphospho-glucuronosyltransferase-1A9 (UGT1A9) expressed in the liver, shows good sequence identity with UGT1A10, expressed in the intestine. Both uridine 5 0 -diphospho-glucuronosyltransferase (UGT) isoforms show comprehensive overlapping substrate selectivity but there are differences in stereoselectivity, regiospecificity and rate of glucuronidation of the substrates. Multiple sequence alignment analyses of UGT1A9 and UGT1A10 showed that 13% of the residues in N-terminal domain (NTD) are non-id… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 70 publications
0
1
0
Order By: Relevance
“…losartan, candesartan, and zolarsartan) are substrates of UGT1A10. [47][48][49] UGT2A3 has no known substrate or biological role (Supplemental Table 3). Previous studies reported a slight increase in UGT1A1 relative expression (~1.4 fold) in CD colon, 20 in line with the (2 fold) increase in UGT1A1 expression in inflamed CD ileum in the current study.…”
Section: Discussionmentioning
confidence: 99%
“…losartan, candesartan, and zolarsartan) are substrates of UGT1A10. [47][48][49] UGT2A3 has no known substrate or biological role (Supplemental Table 3). Previous studies reported a slight increase in UGT1A1 relative expression (~1.4 fold) in CD colon, 20 in line with the (2 fold) increase in UGT1A1 expression in inflamed CD ileum in the current study.…”
Section: Discussionmentioning
confidence: 99%